Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

High Dose Mitoxantrone Based "5+1" Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Neeraj Y Saini, MD, Jan Cerny, MD PhD, Vanessa Furtado, MD, Angela Desmond, Zheng Zhou, Glen D. Raffel, MD, Imran Puthawala, Jayde Bednarik, PharmD, Lindsey Shanahan, Patricia Minehart Miron, PhD, Bruce Woda, MD, Muthalagu Ramanathan, MD, Rajneesh Nath, MD

Blood (2018) 132 (Supplement 1): 1430.

https://doi.org/10.1182/blood-2018-99-116857

Published: 2018

Journal Articles

Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia Patients

Neeraj Y Saini, MD, Jan Cerny, MD PhD, Vanessa Furtado, MD, Imran Puthawala, Angela Desmond, Muthalagu Ramanathan, MD, Rajneesh Nath, MD

Blood (2018) 132 (Supplement 1): 1396.

https://doi.org/10.1182/blood-2018-99-112639

Published: 2018

Journal Articles

Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

Rajneesh Nath, MD, Jan Cerny, MD PhD, Muthalagu Ramanathan, MD, Zheng Zhou, MD PhD, Neng Yu, MD, Glen D Raffel, MD PhD, Jayde Bednarik, PharmD

Blood (2016) 128 (22): 5875.

https://doi.org/10.1182/blood.V128.22.5875.5875

Published: 2016

Journal Articles

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Christopher Strouse, MD, Ying Zhang, Mei-Jie Zhang, PhD, Alyssa DiGilio, MS, Marcelo C. Pasquini, MD, Mary M. Horowitz, MD MS, Stephanie J. Lee, MD, Muthalagu Ramanathan, MD, Wichai Chinratanalab, MD, Alison W Loren, MD MS, Linda J. Burns, MD, Andrew Artz, MD, Kathleen F. Villa, MS, Wael Saber, MD MS

Blood (2016) 128 (22): 983.

https://doi.org/10.1182/blood.V128.22.983.983

Published: 2016

Journal Articles

Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis

Muthalagu Ramanathan, MD, Pierre Teira, MD MS, Minoo Battiwalla, MDMS, A. John Barrett, MD FRCP, FRCPath, Caroline A Lindemans, MD PhD, Jeffery Auletta, MD, Kwang Woo Ahn, PhD, Min Chen, PhD, Marcie L Riches, MD MS, Michael Boeckh, MD

Blood (2014) 124 (21): 47.

https://doi.org/10.1182/blood.V124.21.47.47

Published: 2014

Journal Articles

Unrelated Donor (UD) Cord Blood (CB) Stem Cell Transplantation (SCT) from a Single CB Unit in Older Adults: Excellent Engraftment and Low Early Mortality with a Preparative Regimen of Melphalan (M), Thiotepa (T), Fludarabine(F), and Rabbit (r) Anti Thymocyte Globulin (ATG)

Rajneesh Nath, MD, Muthalagu Ramanathan, MD, Jan Cerny, MD PhD, Zheng Zhou, MD PhD, Glen D Raffel, MD PhD, Jayde Bednarik, Pharm D, Neng Yu, MD, Laura J Petrillo-Deluca, PA-C, Zeina Al-Mansour, MD, Zankar Desai

Blood (2014) 124 (21): 1152.

https://doi.org/10.1182/blood.V124.21.1152.1152

Published: 2014

Journal Articles

High Dose Cyclophosphamide (HDCy) Post Stem Cell Transplant (SCT) Following High Dose Melphalan (HDMel) Based Conditioning As a Dual Strategy For Chemotherapy Dose Intensity and Graft Versus Host Disease (gvhd) Prophylaxis In Matched and Mismatched allogeneic (allo) SCT

Rajneesh Nath, MD, Jan Cerny, MD, Ph.D, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., Jayde Bednarik, Pharm D, Neng Yu, MD, Zankar Desai, Lindsey Shanahan, PA-C, Natasha Fortier, PA-C, Mridula George, MD, Aimee Kroll-Desrosiers, MS

Blood (2013) 122 (21): 4554.

https://doi.org/10.1182/blood.V122.21.4554.4554

Published: 2013

Journal Articles

Optimizing Lentiviral Transduction of Human Natural Killer Cells

Su Su, MD, PhD, Dawn M Betters, Ph.D, Muthalagu Ramanathan, MD, Keyvan Keyvanfar, BS, Aleah Smith, Xingmin Feng, PhD, Elissa Furutani, Mattias Carlsten, MD Ph.D, Andreas Lundqvist, PhD, Richard Childs, MD

Blood (2011) 118 (21): 4714.

https://doi.org/10.1182/blood.V118.21.4714.4714

Published: 2011

Journal Articles

Autologous (Auto) Peripheral Blood Stem Cell (SCT) As a Consolidation Therapy for Patients with Acute Myeloid Leukemia (AML) in 1 st Complete Remission (CR): A Single Institution Experience

Amanpreet Buttar, MD, Deepa Jagadeesh, MD, MPH, Jan Cerny, MD, PhD, Muthalagu Ramanathan, MD, Zheng Zhou, MD, PhD, Laura Petrillo-Deluca, PAC, Natasha Tarrasky, PAC, Jayde Bednarik, Pharm D, Zankar Desai, William V Walsh, MD, Rajneesh Nath, MD

Blood (2011) 118 (21): 4505.

https://doi.org/10.1182/blood.V118.21.4505.4505

Published: 2011

Journal Articles

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

Jan Cerny, MD, PhD, Lesley Woods, MD, Hongbo Yu, MD, PhD, Muthalagu Ramanathan, MD, Glen D Raffel, M.D, Ph.D., William V Walsh, MD, Laura J Petrillo-Deluca, PA-C, Natasha M Tarrasky, PA-C, Elizabeth O'Rourke, NP, Jayde L Bednarik, PharmD, Bruce Woda, MD, Lloyd Hutchinson, PhD, Aimee Kroll, MS, Bruce Barton, PhD, Alan G. Rosmarin, MD, Rajneesh Nath, MD

Blood (2011) 118 (21): 3560.

https://doi.org/10.1182/blood.V118.21.3560.3560

Published: 2011

Journal Articles

High Complete Remission (CR) Rates and Reduced Early Mortality with High Dose Ara-c (HiDAC) and Mitoxantrone (MITO) Induction Chemotherapy for Older (age>60) High Risk Patients with Acute Myeloid Leukemia (AML)

Muthalagu Ramanathan, MD, Zheng Zhou, MD, Jan Cerny, MD, PhD, Glen D Raffel, M.D, Ph.D., Laura Petrillo-Deluca, William Vincent Walsh, MD, Venu Bathini, MD, Micheal Vail, Karen Smethers, Bruce Woda, MD, Patricia Miron, MD, Alan G. Rosmarin, MD, Rajneesh Nath, MD

Blood (2010) 116 (21): 3290.

https://doi.org/10.1182/blood.V116.21.3290.3290

Published: 2010

Journal Articles

Non-Engraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism

Gerald A. Colvin, DO, David Berz, Muthalagu Ramanathan, MD, Eric Winer, MD, Loren D. Fast, PhD, Gerald Jay Elfenbein, MD, Peter J. Quesenberry, MD

Blood (2008) 112 (11): 831.

https://doi.org/10.1182/blood.V112.11.831.831

Published: 2008

NARROW

High Dose Mitoxantrone Based "5+1" Induction Chemotherapy Regimen in Newly Diagnosed Acute Myeloid Leukemia

Hematopoeitic Cell Transplant - Comorbidity Index (HCT-CI) Score Is a Useful Tool for Predicting Induction Mortality and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia Patients

Outcomes of Allogeneic Stem Cell Transplant (Allo-SCT) for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS) in Patients Older Than 75 Years: A Single Center Analysis

Stratification of Allogeneic Hematopoietic Cell Transplant By Risk of Developing Veno-Occlusive Disease: A Model for Assigning a Risk Score

Early CMV Reactivation Still Remains a Cause of Increased Transplant Related Mortality in the Current Era: A CIBMTR Analysis

Unrelated Donor (UD) Cord Blood (CB) Stem Cell Transplantation (SCT) from a Single CB Unit in Older Adults: Excellent Engraftment and Low Early Mortality with a Preparative Regimen of Melphalan (M), Thiotepa (T), Fludarabine(F), and Rabbit (r) Anti Thymocyte Globulin (ATG)

High Dose Cyclophosphamide (HDCy) Post Stem Cell Transplant (SCT) Following High Dose Melphalan (HDMel) Based Conditioning As a Dual Strategy For Chemotherapy Dose Intensity and Graft Versus Host Disease (gvhd) Prophylaxis In Matched and Mismatched allogeneic (allo) SCT

Optimizing Lentiviral Transduction of Human Natural Killer Cells

Autologous (Auto) Peripheral Blood Stem Cell (SCT) As a Consolidation Therapy for Patients with Acute Myeloid Leukemia (AML) in 1 st Complete Remission (CR): A Single Institution Experience

Expression of CD25 on Acute Myeloid Leukemia (AML) Blasts Is An Independent Risk Factor Associated with Refractory Disease, Which May Be Overcome by Stem Cell Transplantation (SCT),

High Complete Remission (CR) Rates and Reduced Early Mortality with High Dose Ara-c (HiDAC) and Mitoxantrone (MITO) Induction Chemotherapy for Older (age>60) High Risk Patients with Acute Myeloid Leukemia (AML)

Non-Engraftment Haploidentical Cellular Immunotherapy for Refractory Malignancies: Tumor Responses without Chimerism

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only